Androgenetic Alopecia Market: By Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia and Others), By Treatment (Pharmaceuticals, Devices and Other Treatment Type), By Gender (Male and Female), By Sales Channel (Prescriptions and OTC), By End Use (Homecare Settings and Dermatology Clinics) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Androgenetic Alopecia Market was valued at USD 3,451.6 million in 2023 and is poised to grow at 8.7% CAGR during the forecast years (2024-2030). Androgenetic Alopecia (AGA), commonly known as male-pattern baldness or female-pattern baldness, is a hereditary condition characterized by progressive hair loss. It is the most common cause of hair loss in both men and women. This condition is linked to genetic predisposition and hormonal changes, particularly the effect of androgens (male hormones) on hair follicles. High rates of androgenetic alopecia among the global population drive demand for treatments. Additionally, rising awareness about hair loss treatments and aesthetic concerns boosts market growth. For instance, International Society of Hair Restoration Surgery (ISHRS) is an organization dedicated to advancing the field of hair restoration surgery. The ISHRS holds annual meetings and provides resources for both patients and professionals, increasing awareness about effective treatments and innovations. However, many hair loss treatments, especially advanced ones, are expensive and not always covered by insurance and that is why it can be the restraining factor.  Whereas, growth in emerging markets offers new opportunities for market expansion.

Androgenetic Alopecia Market Key Developments:
  • In 2023: REVIAN Inc. announced that the Revian Red Hair Growth System is expected to be in a second study. It is anticipated as an effective treatment option for Central Centrifugal Cicatricial Alopecia.
  • In 2023: Pfizer Inc. announced the approval of LITFULO by the U.S. FDA. It is the first treatment that is approved and used for adolescents (12+) to treat severe alopecia areata.
  • In 2023: Sun Pharmaceuticals Industries Ltd announced the acquisition of Concert Pharmaceuticals. The latter is a biotechnology company specializing in treating alopecia areata.

Androgenetic Alopecia Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.7%

Largest Market

North-America

Fastest Growing Market

North-America

Androgenetic Alopecia Market Dynamics

One major driving factor is the increasing prevalence of androgenetic alopecia. This condition affects a significant portion of the global population. For instance, in the U.S., about 50 million men and 30 million women are affected by hair loss due to AGA. Furthermore, in Europe, a substantial percentage of the adult population experiences AGA, with varying degrees of severity. In Asia, especially countries like Japan and China, also shows high prevalence rates, which is driving market growth in these regions. According to the World Health Organization (WHO), about 50% of men and 25% of women worldwide experience some degree of androgenetic alopecia by the age of 50. This reflects the widespread nature of the condition across different demographics and regions.

Androgenetic Alopecia Market Segmentation

By Disease Type

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Androgenetic Alopecia
  • Others

By Treatment

  • Pharmaceuticals
    • Topical
    • Oral
    • PRP 
  • Devices
    • Laser Cap
    • Laser Comb
    • Laser Helmet
  • Other Treatment Type

By Gender

  • Male
  • Female

By Sales Channel

  • Prescriptions
  • OTC

By End User

  • Homecare Settings
  • Dermatology Clinics

Frequently Asked Questions

Androgenetic Alopecia is a genetic condition that causes progressive hair loss, commonly known as male-pattern or female-pattern baldness.

Major driving factors include increasing prevalence of the condition, growing awareness, and advancements in treatment technologies.

Recent developments include the advancement of genetic research and the introduction of new treatments like Kintor Pharmaceutical’s KX-826.

Yes, FDA-approved drugs include Finasteride (Propecia) and Minoxidil (Rogaine).

North America is leading the market due to high awareness, advanced treatment options, and substantial investment in healthcare.

Approximately 50% of men and 25% of women experience androgenetic alopecia by age 50.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global Androgenetic Alopecia Market Introduction 
2.1.Global Androgenetic Alopecia Market  - Taxonomy
2.2.Global Androgenetic Alopecia Market  - Definitions
2.2.1.Disease Type
2.2.2.Treatment 
2.2.3.Gender
2.2.4.Sales Channel
2.2.5.End-user
2.2.6.Region
3.Global Androgenetic Alopecia Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Androgenetic Alopecia Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Androgenetic Alopecia Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Alopecia Areata
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Cicatricial Alopecia
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Traction Alopecia
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Alopecia Totalis
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Alopecia Universalis
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Androgenetic Alopecia
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Androgenetic Alopecia Market  By Treatment , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Pharmaceuticals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Devices
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Other Treatment Type
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Androgenetic Alopecia Market  By Gender, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Male
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Female
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Androgenetic Alopecia Market  By Sales Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Prescriptions
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. OTC
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.Global Androgenetic Alopecia Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Homecare Settings
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Dermatology Clinics
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
10.Global Androgenetic Alopecia Market  By Region, 20110 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. North America
10.1.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.1.3. Market Opportunity Analysis 
10.2. Europe
10.2.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.2.3. Market Opportunity Analysis 
10.3. Asia Pacific (APAC)
10.3.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.3.3. Market Opportunity Analysis 
10.4. Middle East and Africa (MEA)
10.4.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.4.3. Market Opportunity Analysis 
10.5. Latin America
10.5.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.5.3. Market Opportunity Analysis 
11.North America Androgenetic Alopecia Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Alopecia Areata
11.1.2.Cicatricial Alopecia
11.1.3.Traction Alopecia
11.1.4.Alopecia Totalis
11.1.5.Alopecia Universalis
11.1.6.Androgenetic Alopecia
11.1.7.Others
11.2.  Treatment  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Pharmaceuticals
11.2.2.Devices
11.2.3.Other Treatment Type
11.3.  Gender Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Male
11.3.2.Female
11.4.  Sales Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Prescriptions
11.4.2.OTC
11.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Homecare Settings
11.5.2. Dermatology Clinics
11.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.6.1.United States of America (USA)
11.6.2.Canada
12.Europe Androgenetic Alopecia Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Disease Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Alopecia Areata
12.1.2.Cicatricial Alopecia
12.1.3.Traction Alopecia
12.1.4.Alopecia Totalis
12.1.5.Alopecia Universalis
12.1.6.Androgenetic Alopecia
12.1.7.Others
12.2.  Treatment  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Pharmaceuticals
12.2.2.Devices
12.2.3.Other Treatment Type
12.3.  Gender Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Male
12.3.2.Female
12.4.  Sales Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Prescriptions
12.4.2.OTC
12.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.Homecare Settings
12.5.2. Dermatology Clinics
12.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.6.1.Germany
12.6.2.France
12.6.3.Italy
12.6.4.United Kingdom (UK)
12.6.5.Spain
13.Asia Pacific (APAC) Androgenetic Alopecia Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Disease Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Alopecia Areata
13.1.2.Cicatricial Alopecia
13.1.3.Traction Alopecia
13.1.4.Alopecia Totalis
13.1.5.Alopecia Universalis
13.1.6.Androgenetic Alopecia
13.1.7.Others
13.2.  Treatment  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Pharmaceuticals
13.2.2.Devices
13.2.3.Other Treatment Type
13.3.  Gender Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Male
13.3.2.Female
13.4.  Sales Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Prescriptions
13.4.2.OTC
13.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.Homecare Settings
13.5.2. Dermatology Clinics
13.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.6.1.China
13.6.2.India
13.6.3.Australia and New Zealand (ANZ)
13.6.4.Japan
13.6.6.Rest of APAC
14.Middle East and Africa (MEA) Androgenetic Alopecia Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Disease Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Alopecia Areata
14.1.2.Cicatricial Alopecia
14.1.3.Traction Alopecia
14.1.4.Alopecia Totalis
14.1.5.Alopecia Universalis
14.1.6.Androgenetic Alopecia
14.1.7.Others
14.2.  Treatment  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Pharmaceuticals
14.2.2.Devices
14.2.3.Other Treatment Type
14.3.  Gender Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Male
14.3.2.Female
14.4.  Sales Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Prescriptions
14.4.2.OTC
14.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Homecare Settings
14.5.2. Dermatology Clinics
14.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.6.1.GCC Countries
14.6.2.South Africa
14.6.3.Rest of MEA
15.Latin America Androgenetic Alopecia Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15.1. Disease Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.1.1.Alopecia Areata
15.1.2.Cicatricial Alopecia
15.1.3.Traction Alopecia
15.1.4.Alopecia Totalis
15.1.5.Alopecia Universalis
15.1.6.Androgenetic Alopecia
15.1.7.Others
15.2.  Treatment  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.2.1.Pharmaceuticals
15.2.2.Devices
15.2.3.Other Treatment Type
15.3.  Gender Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.3.1.Male
15.3.2.Female
15.4.  Sales Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.4.1.Prescriptions
15.4.2.OTC
15.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.5.1.Homecare Settings
15.5.2. Dermatology Clinics
15.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.6.1.Brazil
15.6.2.Mexico
15.6.3.Rest of LA
16. Competition Landscape
16.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
16.2.1.Johnson & Johnson Services, Inc.
16.2.2.Cipla, Inc.
16.2.3.Sun Pharmaceutical Industries Ltd.
16.2.4.Merck & Co., Inc.
16.2.5.Reddy’s Laboratories Ltd.
16.2.6.Aurobindo Pharma
16.2.7.Lexington Intl., LLC
16.2.8.Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
16.2.9.Curallux, LLC
16.2.10.Apira Science, Inc. (iGROW Laser)
16.2.11.Theradome Inc.
17. Research Methodology 
18. Appendix and Abbreviations 
  • Johnson & Johnson Services, Inc.
  • Cipla, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Reddy’s Laboratories Ltd.
  • Aurobindo Pharma
  • Lexington Intl., LLC
  • Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
  • Curallux, LLC
  • Apira Science, Inc. (iGROW Laser)
  • Theradome Inc.

Adjacent Markets

South Korea Spinal MRI Procedures Market

Spain Spinal MRI Procedures Market

Canada Spinal MRI Procedures Market

France Spinal MRI Procedures Market

Germany Spinal MRI Procedures Market

Peptide Therapeutics Market